Sex-specific association of cardiovascular drug doses with adverse outcomes in atrial fibrillation

In this study of patients with AF, doses of beta-blockers and RAS inhibitors did not differ by sex and were not associated with MACE overall.

Authors

Christine Baumgartner (ORCID: https://orcid.org/0000-0001-6133-5099)
Jürg H. Beer (ORCID: https://orcid.org/0000-0002-7199-0406)
Nicolas Rodondi (ORCID: https://orcid.org/0000-0001-9083-6896)
Jeanne Moor (ORCID: https://orcid.org/0000-0001-8286-618X)
Giorgio Moschovitis (ORCID: https://orcid.org/0000-0002-4043-8061)
Stefan Osswald (ORCID: https://orcid.org/0000-0002-9240-6731)
Seraina Netzer (ORCID: https://orcid.org/0000-0002-3240-0573)
Michael Kühne (ORCID: https://orcid.org/0000-0002-2937-3711)
Carole Clair (ORCID: https://orcid.org/0000-0001-5281-0943)
Angelo Auricchio (ORCID: https://orcid.org/0000-0003-2116-6993)
Leo Hermann Bonati (ORCID: https://orcid.org/0000-0003-1163-8133)
Carole E. Aubert (ORCID: https://orcid.org/0000-0001-8325-8784)
David Conen
Tobias Reichlin (ORCID: https://orcid.org/0000-0002-7197-8415)
Richard Kobza

Institutions

University of Bern (CH)
University of Zurich (CH)
University Hospital of Bern (CH)
University Hospital of Basel (CH)
Population Health Research Institute (CA)
Epatocentro Ticino (CH)
Luzerner Kantonsspital (CH)
Kantonsspital Baden (CH)
Reha Rheinfelden (CH)
University of Lausanne (CH)
McMaster University (CA)

Publication Details

Journal: Open Heart
Published: 2024-08-01
DOI: https://doi.org/10.1136/openhrt-2024-002720
Primary Topic: Atrial Fibrillation Management and Outcomes
Type: article
Field-Weighted Citation Impact: 0.00

Funders

National Science Foundation
Boehringer Ingelheim
Heart Foundation
Amgen
Bristol-Myers Squibb
Pfizer
AstraZeneca
Bayer
Sanofi
Foundation for Cardiovascular Research
Hamilton Health Sciences
Universität Basel
Boston Scientific Corporation
McMaster University
Claret Medical
ZOLL Medical Corporation
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
Daiichi-Sankyo
Schweizerische Herzstiftung
Schweizerische Akademie der Medizinischen Wissenschaften
Servier
MicroPort
Biosense Webster
Daiichi Sankyo Europe

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Sex-specific association of cardiovascular drug doses with adverse outcomes in atrial fibrillation

Christine Baumgartner, Jürg H. Beer, Nicolas Rodondi, Jeanne Moor et al.

Aug 1, 2024

Open Heart

Atrial Fibrillation Management and Outcomes

article

Sex-specific association of cardiovascular drug doses with adverse outcomes in atrial fibrillation

Christine Baumgartner, Jürg H. Beer, Nicolas Rodondi, Jeanne Moor, Giorgio Moschovitis, Stefan Osswald, Seraina Netzer, Michael Kühne, Carole Clair, Angelo Auricchio, Leo Hermann Bonati, Carole E. Aubert, David Conen, Tobias Reichlin, Richard Kobza

August 1, 2024article en

Abstract

In this study of patients with AF, doses of beta-blockers and RAS inhibitors did not differ by sex and were not associated with MACE overall.

Open HeartVol. 11(2)

University of Bern (CH), University of Zurich (CH), University Hospital of Bern (CH), University Hospital of Basel (CH), Population Health Research Institute (CA), Epatocentro Ticino (CH), Luzerner Kantonsspital (CH), Kantonsspital Baden (CH), Reha Rheinfelden (CH), University of Lausanne (CH), McMaster University (CA)

National Science Foundation, Boehringer Ingelheim, Heart Foundation, Amgen, Bristol-Myers Squibb, Pfizer, AstraZeneca, Bayer, Sanofi, Foundation for Cardiovascular Research, Hamilton Health Sciences, Universität Basel, Boston Scientific Corporation, McMaster University, Claret Medical, ZOLL Medical Corporation, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, Daiichi-Sankyo, Schweizerische Herzstiftung, Schweizerische Akademie der Medizinischen Wissenschaften, Servier, MicroPort, Biosense Webster, Daiichi Sankyo Europe

Good health and well-being

Openalex Percentile: Top 76%

Atrial Fibrillation Management and Outcomes

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.